These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 28893472)
1. Canadian school-based HPV vaccine programs and policy considerations. Shapiro GK; Guichon J; Kelaher M Vaccine; 2017 Oct; 35(42):5700-5707. PubMed ID: 28893472 [TBL] [Abstract][Full Text] [Related]
2. Evolution of Public Health Human Papillomavirus Immunization Programs in Canada. Goyette A; Yen GP; Racovitan V; Bhangu P; Kothari S; Franco EL Curr Oncol; 2021 Feb; 28(1):991-1007. PubMed ID: 33617515 [No Abstract] [Full Text] [Related]
3. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada. McClure CA; MacSwain MA; Morrison H; Sanford CJ Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789 [TBL] [Abstract][Full Text] [Related]
5. A Multiple Streams analysis of the decisions to fund gender-neutral HPV vaccination in Canada. Shapiro GK; Guichon J; Prue G; Perez S; Rosberger Z Prev Med; 2017 Jul; 100():123-131. PubMed ID: 28435081 [TBL] [Abstract][Full Text] [Related]
6. HPV Vaccine utilization, Alberta 2008/09-2013/14 School year. Liu XC; Bell CA; Simmonds KA; Russell ML; Svenson LW BMC Infect Dis; 2016 Jan; 16():15. PubMed ID: 26759056 [TBL] [Abstract][Full Text] [Related]
7. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program. Paul P; Fabio A Vaccine; 2014 Jan; 32(3):320-6. PubMed ID: 24295804 [TBL] [Abstract][Full Text] [Related]
8. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada. Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007 [TBL] [Abstract][Full Text] [Related]
9. Coverage from Ontario, Canada's school-based HPV vaccine program: the first three years. Wilson SE; Harris T; Sethi P; Fediurek J; Macdonald L; Deeks SL Vaccine; 2013 Jan; 31(5):757-62. PubMed ID: 23246265 [TBL] [Abstract][Full Text] [Related]
10. Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study. Lim WT; Sears K; Smith LM; Liu G; Lévesque LE BMC Public Health; 2014 Oct; 14():1029. PubMed ID: 25278003 [TBL] [Abstract][Full Text] [Related]
11. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule. Tunis MC; Deeks SL; Can Commun Dis Rep; 2016 Jul; 42(7):149-151. PubMed ID: 29770021 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017. Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Regan DG; Hocking JS; Garland SM; Cornall AM; Atchison S; Bradshaw CS; McNulty A; Owen L; Marshall L; Russell DB; Kaldor JM; Chen MY Vaccine; 2019 Oct; 37(46):6907-6914. PubMed ID: 31562001 [TBL] [Abstract][Full Text] [Related]
13. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594 [TBL] [Abstract][Full Text] [Related]
14. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. Ogilvie G; Anderson M; Marra F; McNeil S; Pielak K; Dawar M; McIvor M; Ehlen T; Dobson S; Money D; Patrick DM; Naus M PLoS Med; 2010 May; 7(5):e1000270. PubMed ID: 20454567 [TBL] [Abstract][Full Text] [Related]
15. A Review of the Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: 10 Years of Clinical Experience in Canada. Steben M; Tan Thompson M; Rodier C; Mallette N; Racovitan V; DeAngelis F; Stutz M; Rampakakis E J Obstet Gynaecol Can; 2018 Dec; 40(12):1635-1645. PubMed ID: 30341021 [TBL] [Abstract][Full Text] [Related]
16. Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study. Perez S; Tatar O; Shapiro GK; Dubé E; Ogilvie G; Guichon J; Gilca V; Rosberger Z BMC Public Health; 2016 Dec; 16(1):1223. PubMed ID: 27919239 [TBL] [Abstract][Full Text] [Related]
18. School-based vaccination programs and the HPV vaccine in 16 Appalachian Kentucky school districts: results from a pilot study. Ely GE; Fields M; Dignan M Soc Work Public Health; 2014; 29(4):368-79. PubMed ID: 24871774 [TBL] [Abstract][Full Text] [Related]
19. Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada. Drolet M; Deeks SL; Kliewer E; Musto G; Lambert P; Brisson M Vaccine; 2016 Apr; 34(16):1874-80. PubMed ID: 26954465 [TBL] [Abstract][Full Text] [Related]
20. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook. Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]